Salomon F, Cuneo R, Sönksen PH. Growth hormone and protein metabolism. Hormones. 1991;36(Suppl. 1):41-3.
 Merimee TJ, Laron Z, LeRoith D. Growth hormone, IGF-I and growth: new view of old concepts. Freund; 1996.
 Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology. 1984 May 1;114(5):1531-6.
 Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DB, Cheng K, Chan WW, Butler B, Hickey G. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences. 1995 Jul 18;92(15):7001-5.
Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, Schneider SH. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. The Journal of Clinical Endocrinology & Metabolism. 1993 Nov 1;77(5):1393-7.
 Copinschi GE, Van Onderbergen AN, L'Hermite-Balériaux M, Mendel CM, Caufriez A, Leproult R, Bolognese JA, De Smet M, Thorner MO, Van Cauter E. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. The Journal of Clinical Endocrinology & Metabolism. 1996 Aug 1;81(8):2776-82.